| 000 | 01091 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250513185358.0 | ||
| 264 | 0 | _c19990826 | |
| 008 | 199908s 0 0 eng d | ||
| 022 | _a0959-8138 | ||
| 024 | 7 |
_a10.1136/bmj.319.7202.123 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTimmis, A D | |
| 245 | 0 | 0 |
_aTreatment of myocardial infarction should be audited before heart failure clinics are set up. _h[electronic resource] |
| 260 |
_bBMJ (Clinical research ed.) _cJul 1999 |
||
| 300 |
_a123 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xtherapeutic use |
| 650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aCardiology Service, Hospital _xorganization & administration |
| 650 | 0 | 4 |
_aHeart Failure _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMedical Audit |
| 650 | 0 | 4 |
_aMyocardial Infarction _xprevention & control |
| 773 | 0 |
_tBMJ (Clinical research ed.) _gvol. 319 _gno. 7202 _gp. 123 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/bmj.319.7202.123 _zAvailable from publisher's website |
| 999 |
_c10356914 _d10356914 |
||